DOX administration in tumor-bearing mice significantly ameliorated the tumor-induced upregulation of IL-1β (Figure 5B), IL-6 (Figure 5C), TNF-α (Figure 5D), and Mcp-1 (Figure 5E). Here, CCL2 is linked to neoplasm.